"Study Reveals Shocking Disparity in Ozempic Production Costs"

A study revealed that it costs less than $5 to produce a month’s supply of the diabetes medication Ozempic, which is sold at a list price of $935.77 for four weekly injections. Lawmakers and patient advocates are pressuring Novo Nordisk to lower the drug's price, with U.S. Senator Bernie Sanders calling for a reduction to no more than its price in Canada, around $300. The advocacy group Patients for Affordable Drugs is also urging legislative action to address the exorbitant prices, while Novo Nordisk has expressed support for policy changes to improve patient affordability and access.